REQUEST A DEMO
Total
USD $0.00
Search more companies

Defensalud Humana Ips S.A.S (Colombia)

Main Activities: Ambulatory Health Care Services
Secondary Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Pharmacies and Drug Stores | Other Ambulatory Health Care Services
Full name: Defensalud Humana Ips S.A.S Profile Updated: March 13, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Spanish Download a sample report

Defensalud Humana Ips S.A.S is based in Colombia, with the head office in La Primavera. The enterprise operates in the Ambulatory Health Care Services industry. It was first established on November 26, 2007. From the latest financial highlights, Defensalud Humana Ips S.A.S reported a net sales revenue increase of 30.35% in 2022. Its’ total assets recorded a growth of 187.82%. In, 2022, the company’s net profit margin decreased by 1.08%.

Headquarters
Cr 7 Cl 9 Brr Estero Lc 4
La Primavera; Vichada;

Contact Details: Purchase the Defensalud Humana Ips S.A.S report to view the information.

Basic Information
Outstanding Shares:
Purchase the Defensalud Humana Ips S.A.S report to view the information.
Incorporation Date:
November 26, 2007
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Defensalud Humana Ips S.A.S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
30.35%
Total operating revenue
30.35%
Operating profit (EBIT)
63.56%
Net Profit (Loss) for the Period
-5.69%
Total assets
187.82%
Total equity
190.75%
Operating Profit Margin (ROS)
1.07%
Net Profit Margin
-1.08%
Return on Equity (ROE)
-9.58%
Quick Ratio
24.8%
Cash Ratio
-5.74%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?